Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for
Forbes - - Results Fail to Demonstrate Meaningful Placebo Adjusted Weight Loss; Obesity Program to be Discontinued - Company to Focus Efforts on Development of Its Pipeline of Four Clinical Stage Products - Company Will Seek to Outlicense Propofol Lingual
Source: www.forbes.com
The Carolina Center To Discuss Quick and Safe Weight Loss on July 17th
dBusinessNews.com - RALEIGH, NC July 9, 2007 As part of his continuing Wellness Series, John C. Pittman, MD, of the Carolina Center for Integrative Medicine (CCIM), will present Lose Weight Quickly & Safely on Tuesday, July 17 th from 7:00-8:00PM. This
Source: triangle.dbusinessnews.com
Kemeta and Obesity Treatment Center Medical Group of Sacramento to
Forbes - Kemeta and OTCMG are collaborating to demonstrate the efficacy of the Kemeta breath analyzer on people engaged in a medically supervised weight loss program. The study is scheduled to begin mid-summer. “The opportunity to collaborate with Dr. Hernried
Source: www.forbes.com

